PET PET
  • My Account
  • Subscribe
Become a Friend Donate
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • My Account
  • Subscribe
  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements
PETBioNewsNewsStudy finds key genes involved in aggressive form of breast cancer

BioNews

Study finds key genes involved in aggressive form of breast cancer

Published 12 November 2012 posted in News and appears in BioNews 610

Author

Dr Rachael Panizzo

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.

Scientists have identified a set of 15 genes that are associated with triple-negative breast cancer (TNBC), an aggressive form of the disease that does not respond to the drugs commonly used to treat other types of breast cancer...

Scientists have identified a set of 15 genes that are associated with triple-negative breast cancer (TNBC), an aggressive form of the disease that does not respond to the drugs commonly used to treat other types of breast cancer.

TNBC accounts for a fifth of all breast cancer cases, and is more common in younger patients, African-American patients and patients with the BRCA1 gene mutation. Approximately 9,000 women are diagnosed with TNBC in Britain each year. Patients with TNBC have a poorer prognosis than women with other types of breast cancer, and have a higher rate of cancer recurrence.

TNBC tumours are known to contain many stem cell-like cells — rapidly-dividing and immature cells. They also lack the molecular receptors — oestrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor 2 (HER2) that are the normal targets of many breast cancer drugs. These drugs are consequently ineffective in TNBC patients.

In the new study, researchers at the Dana-Farber Cancer Institute, affiliated to Harvard Medical School in the US, aimed to identify genes associated with TNBC that could be used as new targets for drug development. By analysing patterns of gene activity in 587 TNBC breast cancer tissue samples from publicly-available datasets, the researchers were able to categorize TNBC tumours into six distinct subtypes based on their unique gene activity profiles.

They identified a set of 15 genes that are required for cell growth in TNBC tumours. These genes are associated with a cell 'signalling pathway' known as Jak2/Stat3. In laboratory tests, TNBC tumour cells were treated with drugs known to block the Jak2/Stat3 signalling pathway, and the researchers found that the drugs suppressed cell growth. The drugs were also effective in suppressing the growth of TNBC tumours in mice.

The research team believes these findings will have immediate clinical implications for TNBC patients. 'The discovery of these targets will rapidly lead to clinical trials with the hope of achieving one of the first specific therapies for triple-negative breast cancers', said Dr Kornelia Polyak, from the Dana-Farber Institute.

The Jak2/Stat3 signalling pathway is known to be involved in certain blood cancers. Two drugs that inhibit this signalling pathway are already in advanced clinical trials, with another three at earlier stages of drug development. The researchers are now beginning clinical trials for one of these drugs in TNBC patients, and estimate that up to 50-60 percent of TNBC patients have an 'abnormally activated' Jak2/Stat3 pathway that may be responsive to this drug treatment.

The researchers also hope to identify 'biomarkers' based on the gene activity profiles of the six TNBC subtypes that could be used to classify breast cancer tumours in patients, and indicate which targeted therapies are likely to be most effective for each person.

Dr Caitlin Palframan, policy manager at Breakthrough Breast Cancer, said: 'This research is very exciting as new treatments for triple-negative breast cancer are urgently needed. There are limited treatment options available for this group of patients so a targeted treatment would be a real breakthrough. However, this is early-stage research in mice and we look forward to seeing if this approach will prove effective in the upcoming clinical trials'. 

The study was published in the Journal of Clinical Investigation.

Related Articles

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
17 January 2013 • 1 minute read

Gene rearrangements behind seven percent of all breast cancers identified

by Sarah Pritchard

Two gene rearrangements associated with prostate and lung cancer could also be behind five to seven percent of all breast cancers, according to US scientists...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
17 January 2013 • 2 minutes read

First genetic link to bone marrow cancer identified

by Zara Mahmoud

Two new gene variants, which each increase the risk of bone marrow cancer by 30 percent, have been identified by scientists at the Institute for Cancer Research...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
22 November 2012 • 2 minutes read

Risk testing during national breast screening could halve cancer rates

by Dr Vivienne Raper

UK women at high risk of breast cancer could halve their chances of developing the disease with genetic risk testing during routine NHS screening. This news came from PROCAS - the world's first study into giving genetic risk and prevention advice in a national breast screening programme, and was reported in this Sunday's Express....

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
21 November 2012 • 2 minutes read

Common cancer gene may change chromosome numbers

by Heidi Colleran

Two US studies published this week have shed light on how a gene mutation can change the number of chromosomes present in the cells of more than 90 percent of cancers...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
12 May 2010 • 2 minutes read

New genetic risks to breast cancer discovered

by Dr Tamara Hirsch

Five new genetic variants have been discovered which, in combination, raise the risk of developing breast cancer by 16 per cent, according to a new study in Nature Genetics...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
22 March 2010 • 3 minutes read

Genetic information doesn't improve breast cancer risk prediction, large study finds

by Dr Rachael Panizzo

Breast cancer risk prediction does not improve significantly when genetic information is included in the risk prediction model, a new study published in the New England Journal of Medicine has found....

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
12 October 2009 • 1 minute read

Faulty gene linked to half of all breast cancers

by Sarah Pritchard

Scientists have discovered a gene which links half of all breast cancers and when damaged, may be responsible for allowing the disease to develop and grow. The researchers noticed that parts of chromosome 8 were missing from tissue which had been removed from 54 breast cancer patients. When they compared the missing area against the information from the Human Genome Project, they discovered it was the NRG1 gene which had been lost....

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
4 October 2009 • 2 minutes read

Welsh women waiting years for cancer genetic test results

by Dr Jay Stone

Edwina Hart, the Welsh Assembly Minister for Health and Social Services, has said that some women in Wales at increased risk of developing hereditary breast cancer are having to wait up to three years to get their genetic test results, while English women are waiting only eight weeks....

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
9 June 2009 • 1 minute read

New breast cancer genes located

by Lorna Stewart

Research published last week in Nature Genetics reports the discovery of two new genes which alter a woman's risk of developing breast cancer. The study, led by Cancer Research UK, was a collaboration between more than 100 scientists across 16 countries. It brings the total number of...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
9 June 2009 • 2 minutes read

Test for breast cancer risk criticised

by Sarah Pritchard

Icelandic biotech company, DeCODE Genetics, last week launched a controversial genetic test to assess a woman's risk of the most common forms of breast cancer. The 1,625 dollar test, which has attracted criticism, comes at a time when new standards of best practice are being drawn up...

Leave a Reply Cancel reply

You must be logged in to post a comment.

« Gene disease association is often exaggerated, study finds

Data-Label The UK's Leading Supplier Of Medical Labels & Asset Labels

RetiringDentist.co.uk The UK's Leading M&A Company.
easyfundraising
amazon

This month in BioNews

  • Popular
  • Recent
13 June 2022 • 2 minutes read

Drop in diversity of blood stem cells leads to old-age health issues

27 June 2022 • 2 minutes read

UK report reveals public attitudes to fertility, genomics and embryo research

27 June 2022 • 2 minutes read

Shortage of sperm donors despite men willing to donate

27 June 2022 • 2 minutes read

North East London CCG proposes offering three funded IVF cycles

27 June 2022 • 2 minutes read

Fibrosis drugs reverse ovarian ageing in mice

27 June 2022 • 2 minutes read

Gene implicated in motor neurone diseases discovered

Subscribe to BioNews and other PET updates for free.

Subscribe
  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856

Subscribe to BioNews and other PET updates for free.

Subscribe
PET PET

PET is an independent charity that improves choices for people affected by infertility and genetic conditions.

  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Navigation

  • About Us
  • Get Involved
  • Donate
  • BioNews
  • Events
  • Engagement
  • Jobs & Opportunities
  • Contact Us

BioNews

  • News
  • Comment
  • Reviews
  • Elsewhere
  • Topics
  • Glossary
  • Newsletters

Other

  • My Account
  • Subscribe

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856